Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task force
Identifieur interne : 001985 ( Main/Curation ); précédent : 001984; suivant : 001986Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task force
Auteurs : Bruno Dubois [France] ; David Burn [Royaume-Uni] ; Christopher Goetz [États-Unis] ; Dag Aarsland [Norvège] ; Richard G. Brown [Royaume-Uni] ; Gerald A. Broe [Australie] ; Dennis Dickson [États-Unis] ; Charles Duyckaerts [France] ; Jefferey Cummings [États-Unis] ; Serge Gauthier [Canada] ; Amos Korczyn [Israël] ; Andrew Lees [Royaume-Uni] ; Richard Levy [France] ; Irene Litvan [États-Unis] ; Yoshikuni Mizuno [Japon] ; Ian G. Mckeith [Royaume-Uni] ; C. Warren Olanow [États-Unis] ; Werner Poewe [Autriche] ; Cristina Sampaio [Portugal] ; Eduardo Tolosa [Espagne] ; Murat Emre [Turquie]Source :
- Movement Disorders [ 0885-3185 ] ; 2007-12-15.
English descriptors
Abstract
A preceding article described the clinical features of Parkinson's disease dementia (PD‐D) and proposed clinical diagnostic criteria for “probable” and “possible” PD‐D. The main focus of this article is to operationalize the diagnosis of PD‐D and to propose pratical guidelines based on a two level process depending upon the clinical scenario and the expertise of the evaluator involved in the assessment. Level I is aimed primarily at the clinician with no particular expertise in neuropsychological methods, but who requires a simple, pragmatic set of tests that are not excessively time‐consuming. Level I can be used alone or in concert with Level II, which is more suitable when there is the need to specify the pattern and the severity on the dementia of PD‐D for clinical monitoring, research studies or pharmacological trials. Level II tests can also be proposed when the diagnosis of PD‐D remains uncertain or equivocal at the end of a Level I evaluation. Given the lack of evidence‐based standards for some tests when applied in this clinical context, we have tried to make practical and unambiguous recommendations, based upon the available literature and the collective experience of the Task Force. We accept, however, that further validation of certain tests and modifications in the recommended cut off values will be required through future studies. © 2007 Movement Disorder Society
Url:
DOI: 10.1002/mds.21844
Links toward previous steps (curation, corpus...)
- to stream Main, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001C57
Links to Exploration step
ISTEX:6E57B2447643E9AF227ECAC3B1DF8B327F449F2DLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task force</title><author><name sortKey="Dubois, Bruno" sort="Dubois, Bruno" uniqKey="Dubois B" first="Bruno" last="Dubois">Bruno Dubois</name><affiliation wicri:level="1"><mods:affiliation>INSERM‐UPMC UMRS 610, Federation of Neurology, AP‐HP, Salpêtrière Hospital; Université Paris6, Paris, France</mods:affiliation><country xml:lang="fr">France</country><wicri:regionArea>INSERM‐UPMC UMRS 610, Federation of Neurology, AP‐HP, Salpêtrière Hospital; Université Paris6, Paris</wicri:regionArea></affiliation></author><author><name sortKey="Burn, David" sort="Burn, David" uniqKey="Burn D" first="David" last="Burn">David Burn</name><affiliation wicri:level="1"><mods:affiliation>Institute for Ageing and Health, Newcastle University, United Kingdom</mods:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Institute for Ageing and Health, Newcastle University</wicri:regionArea></affiliation></author><author><name sortKey="Goetz, Christopher" sort="Goetz, Christopher" uniqKey="Goetz C" first="Christopher" last="Goetz">Christopher Goetz</name><affiliation wicri:level="1"><mods:affiliation>Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois</wicri:regionArea></affiliation></author><author><name sortKey="Aarsland, Dag" sort="Aarsland, Dag" uniqKey="Aarsland D" first="Dag" last="Aarsland">Dag Aarsland</name><affiliation wicri:level="1"><mods:affiliation>Norwegian Centre for Movement Disorders, Stavanger University Hospital, Stavanger, Norway</mods:affiliation><country xml:lang="fr">Norvège</country><wicri:regionArea>Norwegian Centre for Movement Disorders, Stavanger University Hospital, Stavanger</wicri:regionArea></affiliation><affiliation wicri:level="1"><mods:affiliation>School of Medicine, University of Bergen, Norway</mods:affiliation><country xml:lang="fr">Norvège</country><wicri:regionArea>School of Medicine, University of Bergen</wicri:regionArea></affiliation></author><author><name sortKey="Brown, Richard G" sort="Brown, Richard G" uniqKey="Brown R" first="Richard G." last="Brown">Richard G. Brown</name><affiliation wicri:level="1"><mods:affiliation>Department of Psychology, King's College, London, United Kingdom</mods:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Psychology, King's College, London</wicri:regionArea></affiliation><affiliation wicri:level="1"><mods:affiliation>MRC Centre for Neurodegeneration Research, Institute of Psychiatry, King's College, London, United Kingdom</mods:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>MRC Centre for Neurodegeneration Research, Institute of Psychiatry, King's College, London</wicri:regionArea></affiliation></author><author><name sortKey="Broe, Gerald A" sort="Broe, Gerald A" uniqKey="Broe G" first="Gerald A." last="Broe">Gerald A. Broe</name><affiliation wicri:level="1"><mods:affiliation>Ageing Research Centre, Prince of Wales Hospital, Randwick, New South Wales, Australia</mods:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Ageing Research Centre, Prince of Wales Hospital, Randwick, New South Wales</wicri:regionArea></affiliation><affiliation wicri:level="1"><mods:affiliation>Faculty of Medicine, Prince of Wales Medical Research Institute, University of New South Wales, Randwick, New South Wales, Australia</mods:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Faculty of Medicine, Prince of Wales Medical Research Institute, University of New South Wales, Randwick, New South Wales</wicri:regionArea></affiliation></author><author><name sortKey="Dickson, Dennis" sort="Dickson, Dennis" uniqKey="Dickson D" first="Dennis" last="Dickson">Dennis Dickson</name><affiliation wicri:level="1"><mods:affiliation>Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida</wicri:regionArea></affiliation></author><author><name sortKey="Duyckaerts, Charles" sort="Duyckaerts, Charles" uniqKey="Duyckaerts C" first="Charles" last="Duyckaerts">Charles Duyckaerts</name><affiliation wicri:level="1"><mods:affiliation>Neuropathology Laboratory, Salpetriere Hospital, Paris VI Pierre et Marie Curie University, Inserm U679, Paris, France</mods:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Neuropathology Laboratory, Salpetriere Hospital, Paris VI Pierre et Marie Curie University, Inserm U679, Paris</wicri:regionArea></affiliation></author><author><name sortKey="Cummings, Jefferey" sort="Cummings, Jefferey" uniqKey="Cummings J" first="Jefferey" last="Cummings">Jefferey Cummings</name><affiliation wicri:level="1"><mods:affiliation>Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, California, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, California</wicri:regionArea></affiliation></author><author><name sortKey="Gauthier, Serge" sort="Gauthier, Serge" uniqKey="Gauthier S" first="Serge" last="Gauthier">Serge Gauthier</name><affiliation wicri:level="1"><mods:affiliation>Alzheimer Disease and Related Disorders Unit, McGill Center for Studies in Aging, Montreal, Quebec, Canada</mods:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Alzheimer Disease and Related Disorders Unit, McGill Center for Studies in Aging, Montreal, Quebec</wicri:regionArea></affiliation></author><author><name sortKey="Korczyn, Amos" sort="Korczyn, Amos" uniqKey="Korczyn A" first="Amos" last="Korczyn">Amos Korczyn</name><affiliation wicri:level="1"><mods:affiliation>Department of Neurology, Tel‐Aviv University, Ramat ‐Aviv, Israel</mods:affiliation><country xml:lang="fr">Israël</country><wicri:regionArea>Department of Neurology, Tel‐Aviv University, Ramat ‐Aviv</wicri:regionArea></affiliation></author><author><name sortKey="Lees, Andrew" sort="Lees, Andrew" uniqKey="Lees A" first="Andrew" last="Lees">Andrew Lees</name><affiliation wicri:level="1"><mods:affiliation>Department of Neurology, The National Hospital for Neurology and Neurosurgery, Queen Square, London, United Kingdom</mods:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Neurology, The National Hospital for Neurology and Neurosurgery, Queen Square, London</wicri:regionArea></affiliation></author><author><name sortKey="Levy, Richard" sort="Levy, Richard" uniqKey="Levy R" first="Richard" last="Levy">Richard Levy</name><affiliation wicri:level="1"><mods:affiliation>INSERM U610, Hôpital de la Salpêtrière & AP‐HP, Hôpital Saint Antoine, Service de Neurologie, Paris, France</mods:affiliation><country xml:lang="fr">France</country><wicri:regionArea>INSERM U610, Hôpital de la Salpêtrière & AP‐HP, Hôpital Saint Antoine, Service de Neurologie, Paris</wicri:regionArea></affiliation></author><author><name sortKey="Litvan, Irene" sort="Litvan, Irene" uniqKey="Litvan I" first="Irene" last="Litvan">Irene Litvan</name><affiliation wicri:level="1"><mods:affiliation>Movement Disorder Program, Department of Neurology, University of Louisville School of Medicine, Louisville, Kentucky, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Movement Disorder Program, Department of Neurology, University of Louisville School of Medicine, Louisville, Kentucky</wicri:regionArea></affiliation></author><author><name sortKey="Mizuno, Yoshikuni" sort="Mizuno, Yoshikuni" uniqKey="Mizuno Y" first="Yoshikuni" last="Mizuno">Yoshikuni Mizuno</name><affiliation wicri:level="1"><mods:affiliation>Department of Neurology, Research Institute for Diseases of Old Ages, Juntendo University School of Medicine, Bunkyo‐ku, Tokyo, Japan</mods:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Neurology, Research Institute for Diseases of Old Ages, Juntendo University School of Medicine, Bunkyo‐ku, Tokyo</wicri:regionArea></affiliation></author><author><name sortKey="Mckeith, Ian G" sort="Mckeith, Ian G" uniqKey="Mckeith I" first="Ian G." last="Mckeith">Ian G. Mckeith</name><affiliation wicri:level="1"><mods:affiliation>Institute for Ageing and Health, Newcastle University, Newcastle upon Tyne, United Kingdom</mods:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Institute for Ageing and Health, Newcastle University, Newcastle upon Tyne</wicri:regionArea></affiliation></author><author><name sortKey="Olanow, C Warren" sort="Olanow, C Warren" uniqKey="Olanow C" first="C. Warren" last="Olanow">C. Warren Olanow</name><affiliation wicri:level="1"><mods:affiliation>Department of Neurology, Mount Sinai School of Medicine, New York, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, Mount Sinai School of Medicine, New York</wicri:regionArea></affiliation><affiliation wicri:level="1"><mods:affiliation>Department of Neuroscience, Mount Sinai School of Medicine, New York, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neuroscience, Mount Sinai School of Medicine, New York</wicri:regionArea></affiliation></author><author><name sortKey="Poewe, Werner" sort="Poewe, Werner" uniqKey="Poewe W" first="Werner" last="Poewe">Werner Poewe</name><affiliation wicri:level="1"><mods:affiliation>Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria</mods:affiliation><country xml:lang="fr">Autriche</country><wicri:regionArea>Department of Neurology, Medical University of Innsbruck, Innsbruck</wicri:regionArea></affiliation></author><author><name sortKey="Sampaio, Cristina" sort="Sampaio, Cristina" uniqKey="Sampaio C" first="Cristina" last="Sampaio">Cristina Sampaio</name><affiliation wicri:level="1"><mods:affiliation>Laboratorio de Farmacologia Clinica e Terapeutica, Faculdade de Medicina de Lisboa e Instituto de Medicina Molecular, Lisboa, Portugal</mods:affiliation><country xml:lang="fr">Portugal</country><wicri:regionArea>Laboratorio de Farmacologia Clinica e Terapeutica, Faculdade de Medicina de Lisboa e Instituto de Medicina Molecular, Lisboa</wicri:regionArea></affiliation></author><author><name sortKey="Tolosa, Eduardo" sort="Tolosa, Eduardo" uniqKey="Tolosa E" first="Eduardo" last="Tolosa">Eduardo Tolosa</name><affiliation wicri:level="1"><mods:affiliation>Parkinson's Disease and Movement Disorders Unit, Neurology Service, Institut Clinic de Neurociences, Hospital Clinic de Barcelona, IDIBAPS, Universitat de Barcelona, CIBERNED, Barcelona, Catalonia, Spain</mods:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Parkinson's Disease and Movement Disorders Unit, Neurology Service, Institut Clinic de Neurociences, Hospital Clinic de Barcelona, IDIBAPS, Universitat de Barcelona, CIBERNED, Barcelona, Catalonia</wicri:regionArea></affiliation></author><author><name sortKey="Emre, Murat" sort="Emre, Murat" uniqKey="Emre M" first="Murat" last="Emre">Murat Emre</name><affiliation wicri:level="1"><mods:affiliation>Department of Neurology, Behavioral Neurology and Movement Disorders Unit, Ístanbul Faculty of Medicine, Ístanbul University, Ístanbul, Turkey</mods:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Department of Neurology, Behavioral Neurology and Movement Disorders Unit, Ístanbul Faculty of Medicine, Ístanbul University, Ístanbul</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:6E57B2447643E9AF227ECAC3B1DF8B327F449F2D</idno><date when="2007" year="2007">2007</date><idno type="doi">10.1002/mds.21844</idno><idno type="url">https://api.istex.fr/document/6E57B2447643E9AF227ECAC3B1DF8B327F449F2D/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">001C57</idno><idno type="wicri:Area/Main/Curation">001985</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task force</title><author><name sortKey="Dubois, Bruno" sort="Dubois, Bruno" uniqKey="Dubois B" first="Bruno" last="Dubois">Bruno Dubois</name><affiliation wicri:level="1"><mods:affiliation>INSERM‐UPMC UMRS 610, Federation of Neurology, AP‐HP, Salpêtrière Hospital; Université Paris6, Paris, France</mods:affiliation><country xml:lang="fr">France</country><wicri:regionArea>INSERM‐UPMC UMRS 610, Federation of Neurology, AP‐HP, Salpêtrière Hospital; Université Paris6, Paris</wicri:regionArea></affiliation></author><author><name sortKey="Burn, David" sort="Burn, David" uniqKey="Burn D" first="David" last="Burn">David Burn</name><affiliation wicri:level="1"><mods:affiliation>Institute for Ageing and Health, Newcastle University, United Kingdom</mods:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Institute for Ageing and Health, Newcastle University</wicri:regionArea></affiliation></author><author><name sortKey="Goetz, Christopher" sort="Goetz, Christopher" uniqKey="Goetz C" first="Christopher" last="Goetz">Christopher Goetz</name><affiliation wicri:level="1"><mods:affiliation>Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois</wicri:regionArea></affiliation></author><author><name sortKey="Aarsland, Dag" sort="Aarsland, Dag" uniqKey="Aarsland D" first="Dag" last="Aarsland">Dag Aarsland</name><affiliation wicri:level="1"><mods:affiliation>Norwegian Centre for Movement Disorders, Stavanger University Hospital, Stavanger, Norway</mods:affiliation><country xml:lang="fr">Norvège</country><wicri:regionArea>Norwegian Centre for Movement Disorders, Stavanger University Hospital, Stavanger</wicri:regionArea></affiliation><affiliation wicri:level="1"><mods:affiliation>School of Medicine, University of Bergen, Norway</mods:affiliation><country xml:lang="fr">Norvège</country><wicri:regionArea>School of Medicine, University of Bergen</wicri:regionArea></affiliation></author><author><name sortKey="Brown, Richard G" sort="Brown, Richard G" uniqKey="Brown R" first="Richard G." last="Brown">Richard G. Brown</name><affiliation wicri:level="1"><mods:affiliation>Department of Psychology, King's College, London, United Kingdom</mods:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Psychology, King's College, London</wicri:regionArea></affiliation><affiliation wicri:level="1"><mods:affiliation>MRC Centre for Neurodegeneration Research, Institute of Psychiatry, King's College, London, United Kingdom</mods:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>MRC Centre for Neurodegeneration Research, Institute of Psychiatry, King's College, London</wicri:regionArea></affiliation></author><author><name sortKey="Broe, Gerald A" sort="Broe, Gerald A" uniqKey="Broe G" first="Gerald A." last="Broe">Gerald A. Broe</name><affiliation wicri:level="1"><mods:affiliation>Ageing Research Centre, Prince of Wales Hospital, Randwick, New South Wales, Australia</mods:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Ageing Research Centre, Prince of Wales Hospital, Randwick, New South Wales</wicri:regionArea></affiliation><affiliation wicri:level="1"><mods:affiliation>Faculty of Medicine, Prince of Wales Medical Research Institute, University of New South Wales, Randwick, New South Wales, Australia</mods:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Faculty of Medicine, Prince of Wales Medical Research Institute, University of New South Wales, Randwick, New South Wales</wicri:regionArea></affiliation></author><author><name sortKey="Dickson, Dennis" sort="Dickson, Dennis" uniqKey="Dickson D" first="Dennis" last="Dickson">Dennis Dickson</name><affiliation wicri:level="1"><mods:affiliation>Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida</wicri:regionArea></affiliation></author><author><name sortKey="Duyckaerts, Charles" sort="Duyckaerts, Charles" uniqKey="Duyckaerts C" first="Charles" last="Duyckaerts">Charles Duyckaerts</name><affiliation wicri:level="1"><mods:affiliation>Neuropathology Laboratory, Salpetriere Hospital, Paris VI Pierre et Marie Curie University, Inserm U679, Paris, France</mods:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Neuropathology Laboratory, Salpetriere Hospital, Paris VI Pierre et Marie Curie University, Inserm U679, Paris</wicri:regionArea></affiliation></author><author><name sortKey="Cummings, Jefferey" sort="Cummings, Jefferey" uniqKey="Cummings J" first="Jefferey" last="Cummings">Jefferey Cummings</name><affiliation wicri:level="1"><mods:affiliation>Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, California, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, California</wicri:regionArea></affiliation></author><author><name sortKey="Gauthier, Serge" sort="Gauthier, Serge" uniqKey="Gauthier S" first="Serge" last="Gauthier">Serge Gauthier</name><affiliation wicri:level="1"><mods:affiliation>Alzheimer Disease and Related Disorders Unit, McGill Center for Studies in Aging, Montreal, Quebec, Canada</mods:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Alzheimer Disease and Related Disorders Unit, McGill Center for Studies in Aging, Montreal, Quebec</wicri:regionArea></affiliation></author><author><name sortKey="Korczyn, Amos" sort="Korczyn, Amos" uniqKey="Korczyn A" first="Amos" last="Korczyn">Amos Korczyn</name><affiliation wicri:level="1"><mods:affiliation>Department of Neurology, Tel‐Aviv University, Ramat ‐Aviv, Israel</mods:affiliation><country xml:lang="fr">Israël</country><wicri:regionArea>Department of Neurology, Tel‐Aviv University, Ramat ‐Aviv</wicri:regionArea></affiliation></author><author><name sortKey="Lees, Andrew" sort="Lees, Andrew" uniqKey="Lees A" first="Andrew" last="Lees">Andrew Lees</name><affiliation wicri:level="1"><mods:affiliation>Department of Neurology, The National Hospital for Neurology and Neurosurgery, Queen Square, London, United Kingdom</mods:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Neurology, The National Hospital for Neurology and Neurosurgery, Queen Square, London</wicri:regionArea></affiliation></author><author><name sortKey="Levy, Richard" sort="Levy, Richard" uniqKey="Levy R" first="Richard" last="Levy">Richard Levy</name><affiliation wicri:level="1"><mods:affiliation>INSERM U610, Hôpital de la Salpêtrière & AP‐HP, Hôpital Saint Antoine, Service de Neurologie, Paris, France</mods:affiliation><country xml:lang="fr">France</country><wicri:regionArea>INSERM U610, Hôpital de la Salpêtrière & AP‐HP, Hôpital Saint Antoine, Service de Neurologie, Paris</wicri:regionArea></affiliation></author><author><name sortKey="Litvan, Irene" sort="Litvan, Irene" uniqKey="Litvan I" first="Irene" last="Litvan">Irene Litvan</name><affiliation wicri:level="1"><mods:affiliation>Movement Disorder Program, Department of Neurology, University of Louisville School of Medicine, Louisville, Kentucky, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Movement Disorder Program, Department of Neurology, University of Louisville School of Medicine, Louisville, Kentucky</wicri:regionArea></affiliation></author><author><name sortKey="Mizuno, Yoshikuni" sort="Mizuno, Yoshikuni" uniqKey="Mizuno Y" first="Yoshikuni" last="Mizuno">Yoshikuni Mizuno</name><affiliation wicri:level="1"><mods:affiliation>Department of Neurology, Research Institute for Diseases of Old Ages, Juntendo University School of Medicine, Bunkyo‐ku, Tokyo, Japan</mods:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Neurology, Research Institute for Diseases of Old Ages, Juntendo University School of Medicine, Bunkyo‐ku, Tokyo</wicri:regionArea></affiliation></author><author><name sortKey="Mckeith, Ian G" sort="Mckeith, Ian G" uniqKey="Mckeith I" first="Ian G." last="Mckeith">Ian G. Mckeith</name><affiliation wicri:level="1"><mods:affiliation>Institute for Ageing and Health, Newcastle University, Newcastle upon Tyne, United Kingdom</mods:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Institute for Ageing and Health, Newcastle University, Newcastle upon Tyne</wicri:regionArea></affiliation></author><author><name sortKey="Olanow, C Warren" sort="Olanow, C Warren" uniqKey="Olanow C" first="C. Warren" last="Olanow">C. Warren Olanow</name><affiliation wicri:level="1"><mods:affiliation>Department of Neurology, Mount Sinai School of Medicine, New York, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, Mount Sinai School of Medicine, New York</wicri:regionArea></affiliation><affiliation wicri:level="1"><mods:affiliation>Department of Neuroscience, Mount Sinai School of Medicine, New York, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neuroscience, Mount Sinai School of Medicine, New York</wicri:regionArea></affiliation></author><author><name sortKey="Poewe, Werner" sort="Poewe, Werner" uniqKey="Poewe W" first="Werner" last="Poewe">Werner Poewe</name><affiliation wicri:level="1"><mods:affiliation>Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria</mods:affiliation><country xml:lang="fr">Autriche</country><wicri:regionArea>Department of Neurology, Medical University of Innsbruck, Innsbruck</wicri:regionArea></affiliation></author><author><name sortKey="Sampaio, Cristina" sort="Sampaio, Cristina" uniqKey="Sampaio C" first="Cristina" last="Sampaio">Cristina Sampaio</name><affiliation wicri:level="1"><mods:affiliation>Laboratorio de Farmacologia Clinica e Terapeutica, Faculdade de Medicina de Lisboa e Instituto de Medicina Molecular, Lisboa, Portugal</mods:affiliation><country xml:lang="fr">Portugal</country><wicri:regionArea>Laboratorio de Farmacologia Clinica e Terapeutica, Faculdade de Medicina de Lisboa e Instituto de Medicina Molecular, Lisboa</wicri:regionArea></affiliation></author><author><name sortKey="Tolosa, Eduardo" sort="Tolosa, Eduardo" uniqKey="Tolosa E" first="Eduardo" last="Tolosa">Eduardo Tolosa</name><affiliation wicri:level="1"><mods:affiliation>Parkinson's Disease and Movement Disorders Unit, Neurology Service, Institut Clinic de Neurociences, Hospital Clinic de Barcelona, IDIBAPS, Universitat de Barcelona, CIBERNED, Barcelona, Catalonia, Spain</mods:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Parkinson's Disease and Movement Disorders Unit, Neurology Service, Institut Clinic de Neurociences, Hospital Clinic de Barcelona, IDIBAPS, Universitat de Barcelona, CIBERNED, Barcelona, Catalonia</wicri:regionArea></affiliation></author><author><name sortKey="Emre, Murat" sort="Emre, Murat" uniqKey="Emre M" first="Murat" last="Emre">Murat Emre</name><affiliation wicri:level="1"><mods:affiliation>Department of Neurology, Behavioral Neurology and Movement Disorders Unit, Ístanbul Faculty of Medicine, Ístanbul University, Ístanbul, Turkey</mods:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Department of Neurology, Behavioral Neurology and Movement Disorders Unit, Ístanbul Faculty of Medicine, Ístanbul University, Ístanbul</wicri:regionArea></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2007-12-15">2007-12-15</date><biblScope unit="volume">22</biblScope><biblScope unit="issue">16</biblScope><biblScope unit="page" from="2314">2314</biblScope><biblScope unit="page" to="2324">2324</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">6E57B2447643E9AF227ECAC3B1DF8B327F449F2D</idno><idno type="DOI">10.1002/mds.21844</idno><idno type="ArticleID">MDS21844</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>PD dementia</term><term>Parkinson's disease</term><term>diagnostic criteria</term><term>executive functions</term><term>task force</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">A preceding article described the clinical features of Parkinson's disease dementia (PD‐D) and proposed clinical diagnostic criteria for “probable” and “possible” PD‐D. The main focus of this article is to operationalize the diagnosis of PD‐D and to propose pratical guidelines based on a two level process depending upon the clinical scenario and the expertise of the evaluator involved in the assessment. Level I is aimed primarily at the clinician with no particular expertise in neuropsychological methods, but who requires a simple, pragmatic set of tests that are not excessively time‐consuming. Level I can be used alone or in concert with Level II, which is more suitable when there is the need to specify the pattern and the severity on the dementia of PD‐D for clinical monitoring, research studies or pharmacological trials. Level II tests can also be proposed when the diagnosis of PD‐D remains uncertain or equivocal at the end of a Level I evaluation. Given the lack of evidence‐based standards for some tests when applied in this clinical context, we have tried to make practical and unambiguous recommendations, based upon the available literature and the collective experience of the Task Force. We accept, however, that further validation of certain tests and modifications in the recommended cut off values will be required through future studies. © 2007 Movement Disorder Society</div></front></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001985 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 001985 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Curation
|type= RBID
|clé= ISTEX:6E57B2447643E9AF227ECAC3B1DF8B327F449F2D
|texte= Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task force
}}
| This area was generated with Dilib version V0.6.23. |  |